The Discounted Cash Flow (DCF) valuation of Palla Pharma Ltd (PAL.AX) is (104.72) AUD. With the latest stock price at 0.30 AUD, the upside of Palla Pharma Ltd based on DCF is -35599.1%.
Based on the latest price of 0.30 AUD and our DCF valuation, Palla Pharma Ltd (PAL.AX) is a sell. selling PAL.AX stocks now will result in a potential gain of 35599.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.2% | 6.1% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (920.52) - (56.15) | (104.72) |
| Upside | -312141.7% - -19135.4% | -35599.1% |